Syncope, commonly known as fainting, is a transient loss of consciousness, often accompanied by a loss of postural tone. Despite being a common clinical problem, it often poses diagnostic and management challenges to healthcare professionals due to its multifactorial etiology.
Syncope can be classified into three main categories: reflex or neurally mediated, orthostatic hypotension, and cardiac syncope. Reflex syncope is the most common, often triggered by emotional distress or pain. Orthostatic hypotension is usually due to medications or dehydration. Cardiac syncope, although less common, is the most concerning as it may indicate underlying heart disease.
A thorough history and physical examination are crucial in diagnosing syncope. Key elements include the circumstances preceding the event, presence of prodromal symptoms, and post-event recovery. Diagnostic tests, such as electrocardiography (ECG), may be necessary for patients with suspected cardiac syncope. In some cases, tilt-table testing, carotid sinus massage, or implantable loop recorders may also be used.
Management of syncope is largely dependent on the underlying cause. For reflex syncope, reassurance and lifestyle modifications are often sufficient. Orthostatic hypotension may require medication adjustments or increased fluid and salt intake. Cardiac syncope warrants further investigation and may necessitate interventions like pacemaker implantation or cardiac surgery.
Syncope, while common, should not be trivialized. A systematic approach to diagnosis, including a detailed history, physical examination, and appropriate diagnostic testing, can help identify the underlying cause. Management should be tailored to the individual patient's needs and underlying etiology. Through a comprehensive understanding and approach, healthcare professionals can effectively diagnose and manage syncope, improving patient outcomes and quality of life.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation